Kintara Therapeutics Interest Expense 2011-2025 | KTRA

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Kintara Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.14 M	18.7 K	-	30 K	-	-	-	-	-	2.09 K	-8.14 K	8.02 K	7.52 K	21.9 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.14 M	-8.14 K	527 K

Quarterly Interest Expense Kintara Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
16.5 K	352 K	353 K	-	2 M	1.36 M	255 K	-	-	-	-	-	-	-	-	23 K	-	7 K	8 K	8 K	16 K	8 K	-	-	-	-	-	-	-	-	-	-	-	84.2 K	-	1.23 M	-	-280 K	-	2.09 K	-	-	-	-2.09 K	-2.09 K	-2.09 K	-2.04 K	-2.03 K	1.99 K	1.96 K	-	1.9 K	1.88 K	1.86 K	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2 M	-280 K	209 K